New heart valve repair without open surgery: could it help High-Risk patients?
NCT ID NCT06700239
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called the MIA-T system, which is inserted through a catheter to repair the tricuspid valve in people with severe leakage. The trial will enroll 600 patients who are too high-risk for traditional surgery. The goal is to see if the device safely improves symptoms, reduces hospitalizations, and lowers the risk of death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MIA-T device (a catheter-based implant to repair the tricuspid valve)
What this could lead to
If successful, this could offer a safer, less invasive option for people with severe tricuspid regurgitation who cannot have open-heart surgery, potentially reducing hospitalizations and improving survival.
What could go wrong
This is a large but early-stage pivotal trial; the device may not work as well as hoped, and risks include heart-related complications, kidney failure, or infection. Long-term benefits are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••